STOCK TITAN

NDT Pharmaceuticals (NDTP) Stock Price, News & Analysis

NDTP OTC
Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
126 191 sessions, November 5, 2025 to November 5, 2026
Largest daily move
+100% close of May 22, 2026
1-year change
-98.5% closing prices, November 5, 2025 to November 5, 2026
1-month change
-94.1% closing prices, October 2, 2026 to November 5, 2026

Company Description

NDT Pharmaceuticals, Inc. (NDTP) is a publicly traded healthcare company in the biotechnology and broader health and wellness space. According to company disclosures, NDT Pharmaceuticals focuses on advancing innovative consumer health and wellness solutions. The company’s strategy centers on sustainable, science-driven brands that protect people, pets, and the planet, aligning its product portfolio with growing demand for eco-friendly and health-conscious alternatives.

A core element of NDT Pharmaceuticals’ business model is its wholly owned subsidiary, Good Salt Life, Inc., an Athens, Georgia-based biosafety and infection control company. Through this subsidiary, NDT Pharmaceuticals participates in markets that span consumer products, institutional disinfection, and biosecurity technologies. Good Salt Life is described as a vertically integrated biosafety company that designs, manufactures, and deploys infection control and hygiene ecosystems that combine proprietary hardware, EPA-approved chemistries, and data-driven disinfection protocols.

Good Salt Life and the Biosafety Ecosystem

Good Salt Life’s biosafety ecosystem is built around proprietary disinfectant formulations and specialized delivery hardware. Company materials highlight the Clean Republic brand, which includes a hypochlorous acid (HOCl) disinfectant and a Clean Republic Multipurpose Disinfectant engineered using advanced salt-based chemistry. These formulations are described as hospital-grade, non-toxic, non-VOC, and designed for use in sensitive environments such as healthcare, food service, education, animal care, and other professional settings.

The ecosystem also incorporates proprietary dispensing and application technologies. Examples include the ByoCart and ByoCart Sprayer units, professional-grade, high-output sprayer systems intended for efficient coverage of large facilities, and induction-charged spray and air-scrubbing technologies that support both surface disinfection and air quality improvements. These systems are presented as institutional-grade solutions for hospitals, correctional facilities, cruise ships, and other high-density environments where infection control and environmental hygiene are critical.

Consumer, Pet, and Home Care Brands

Beyond institutional biosafety, Good Salt Life manages a portfolio of consumer-facing brands that extend NDT Pharmaceuticals’ presence into home, pet, and personal care markets. The company describes a growing catalog of eco-friendly, science-backed products for home, pet, and professional environments. Notable brands and product lines mentioned in company communications include:

  • Dog Gone Odor: A premier pet care brand featuring EPA-registered antimicrobial solutions and odor-killing bacteria chemistry for companion animals. The product line includes a waterless probiotic shampoo and deodorizing sprays that neutralize odor-causing bacteria at the source and is positioned as safe for sensitive skin.
  • PurrGuard: An EPA-registered odor-control chemistry brand focused on feline environments, designed to combat odor-causing microorganisms on treated surfaces in pet-focused settings.
  • Clean Republic: Hospital-grade, salt-based disinfectants and multipurpose disinfectant products formulated for professional and institutional cleaning markets.
  • Fresh Extend: Natural fruit and vegetable washes described as part of Good Salt Life’s eco-friendly catalog.
  • Good Salt Living: Personal care and wellness essentials, including items such as skin toners and oral rinses.

These brands reflect NDT Pharmaceuticals’ emphasis on non-toxic, environmentally conscious formulations that aim to provide measurable efficacy while maintaining safety for people and animals.

Regulatory and EPA-Registered Solutions

Regulatory positioning is a recurring theme in NDT Pharmaceuticals’ and Good Salt Life’s disclosures. Good Salt Life has obtained U.S. Environmental Protection Agency (EPA) approvals related to antimicrobial and odor-control products. For example, the company reports that the EPA granted the use of alternate brand names PurrGuard and Dog Gone Odor under the SabreTech QS registration (EPA Registration No. 103738-2), a federally registered antimicrobial product formulated to combat odor-causing microorganisms on treated surfaces. These EPA-registered-for-use solutions are designed for the companion animal market and can be applied to both porous and non-porous surfaces in homes, shelters, kennels, grooming facilities, and veterinary settings.

Good Salt Life has also submitted a "me-too" registration application to the EPA for its hypochlorous acid disinfectant, seeking an expanded label that, if approved, would include an efficacy claim for Clostridioides difficile (C. diff). Company statements emphasize that Clean Republic Multipurpose Disinfectant is undergoing multiple regulatory and third-party reviews, including federal review tied to enhanced pathogen performance standards and independent sustainability and environmental impact assessments.

Institutional and Government Markets

Through Good Salt Life, NDT Pharmaceuticals participates in institutional markets where hygiene, infection control, and biosafety are central concerns. Company announcements describe deployments and contracts in several sectors:

  • Healthcare facilities: Good Salt Life’s ByoCart Disinfection System has been deployed at Baptist Hospital, the flagship facility of Baptist Health, to enhance infection prevention and environmental safety. The system is described as providing integrated surface and air protection through induction-charged air-scrubbing technology and precise surface application.
  • Correctional institutions: The Tennessee Department of Correction (TDOC) has purchased ByoCart Sprayer units and Clean Republic Disinfectant to modernize hygiene and infection-control protocols across correctional facilities. The biosafety ecosystem is presented as addressing employee safety, infection control, and security considerations through non-toxic, non-fuming, and non-flammable disinfectant solutions.
  • Cruise lines and hospitality: Good Salt Life has an expanded relationship with Norwegian Cruise Line (NCL), which has ordered induction-charged disinfectant sprayers to deploy EPA-approved, eco-friendly HOCl solutions throughout communal areas and staterooms. Company materials also reference customers in hospitality and transportation sectors.
  • Animal health and equine environments: Good Salt Life has deployed EPA-registered disinfectants and induction charge delivery systems in response to an Equine Herpesvirus-1 (EHV-1) outbreak affecting performance horses, working with veterinarians and event organizers to implement biosecurity measures.

These activities illustrate how NDT Pharmaceuticals, via Good Salt Life, applies its biosafety technologies across a range of human and animal environments.

AI-Robotics and Advanced Application Technologies

NDT Pharmaceuticals reports that Good Salt Life is integrating AI-robotics into its disinfection processes, particularly for unmanned hospital disinfection. This approach leverages induction-charged spray technology combined with non-toxic chemical solutions that are described as safe for human inhalation and skin contact. The company positions this AI-robotic innovation as a way to deliver consistent and thorough disinfection in healthcare settings and to complement existing disinfectant products such as Clean Republic Multipurpose Disinfectant.

Good Salt Life also references advanced air-scrubbing and induction-charged spray technologies designed to improve surface coverage, enhance consistency, and minimize chemical overuse. These technologies are presented as aligning with sustainability and environmental responsibility goals while supporting higher biosecurity standards.

Corporate Strategy and Focus

Across its communications, NDT Pharmaceuticals characterizes its corporate strategy as building value through investments in sustainable, science-driven brands that promote healthier living. The acquisition of Good Salt Life is described as a transformative step that expanded NDT Pharmaceuticals’ strategic direction into biosafety, infection control, and eco-friendly consumer products. The company highlights its focus on measurable efficacy, regulatory credibility, and environmental responsibility in both consumer and institutional markets.

Stock Performance

$0.0348
+132.00%
+0.0198
Last updated: November 6, 2026 at 11:40
-98.5%
Performance 1 year

NDT Pharmaceuticals (NDTP) closed at $0.0150 on November 5, 2026. Over the past 12 months, the price has lost 98.5%.

See what a $1,000 investment in NDTP would be worth today

Average down calculator for NDTP

NDTP Metrics & Rankings

Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

NDT Pharmaceuticals has 10 recent news articles. Of the recent coverage, 4 articles coincided with positive price movement and 5 with negative movement. Key topics include AI. View all NDTP news →

SEC Filings

No SEC filings available for NDTP.

Short Interest History

Last 12 Months

Short interest in NDT Pharmaceuticals (NDTP) currently stands at 1.1 thousand shares, a new position with no short interest reported in the previous period, representing 0.0% of the float. Since November 2025, short interest has decreased by 83.7%.

Days to Cover History

Last 12 Months

Days to cover for NDT Pharmaceuticals (NDTP) currently stands at 1.0 days. The ratio is the reported short interest divided by the average daily trading volume. Across the settlements charted above, it has ranged from 0.0 to 3.3 days.

NDTP Company Profile & Sector Positioning

NDT Pharmaceuticals (NDTP) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC.

Investors comparing NDTP often look at related companies in the same sector, including Onco-Innovations Ltd (ONNVF), Pharmala Biotech Holding Inc (MDXXF), Devonian Hlth Group Inc (DVHGF), Synlogic Inc (SYBX), and Lobe Sciences Ltd (LOBEF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate NDTP's relative position within its industry.

Frequently Asked Questions

The current stock price of NDT Pharmaceuticals (NDTP) is $0.0348 as of November 6, 2026.

The market cap of NDT Pharmaceuticals (NDTP) is approximately $7.9M. Learn more about what market capitalization means .